Gul Dusi

Prior to the COVID-19 pandemic, the bio/pharma manufacturing industry had been relatively slow to embrace the ongoing digital revolution. But the pandemic forced the life sciences industry and drug developers to rethink their hesitation toward digitization to quickly produce and distribute new vaccines under unprecedented conditions. Now, technology is being used as a solution to improve efficiency and sustainability in life sciences manufacturing. Those who have led the way are said to be creating the “lighthouse effect.” Just as actual lighthouses help sailors navigate dangerous waters, lighthouse companies serve as guiding lights for charting the course of an entire industry. For the life sciences manufacturing industry, becoming one of these luminaries relies on a mix of advanced technical capabilities and coming up with innovative applications for the technology. In the age of Big Data, artificial intelligence (AI) and digitization will play lead roles in achieving lighthouse effects.

Converting Injectable Therapies to Combination Drug-Device Products

Read this article in the Trends in Manufacturing ebook.

1. World Economic Forum and McKinsey & Company, “Global Lighthouse Network: Reimagining Operations for Growth,” Whitepaper, 2021.

2. C. Schmidt, “Machine Learning Poised to Accelerate Drug Discovery,” Novartis, May 7, 2018

When referring to this article, please cite it as G. Dusi, “The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing,” 

Pharmaceutical Technology Trends in Manufacturing

Articles

Lighthouse manufacturing techniques utilize technology and automation to
streamline production.